Crc

crc@lists.oulu.fi

13 participants
4894 discussions

FW: Tiedote kontinkankaan ilmanvaihtokoneiden pakkaspudotuksiin.
by Virpi Glumoff 28 Jan '19

28 Jan '19

Hei kaikki / dear all Kovan pakkasen takia osa Kontikankaan kampuksen vetokaapeista käy puoliteholla eikä maksimivirtauspainike toimi. Ottakaa tämä huomioon myrkyllisten/haitallisten aineiden käsittelyssä. Due to the cold weather some of the fume hoods in Kontinkangas campus are running at half speed and the maximum flow button is not operational. Please take this in consideration when handling harmful/toxic substances. tilahallinnon puolesta -virpi From: Pertti Hoskio Sent: maanantai 28. tammikuuta 2019 7.49 To: Sakari Kellokumpu <sakari.kellokumpu(a)oulu.fi>; Virpi Glumoff <virpi.glumoff(a)oulu.fi>; Tuula Taskinen <tuula.taskinen(a)oulu.fi> Cc: Juhani Vänttilä <juhani.vanttila(a)oulu.fi> Subject: VL: Tiedote kontinkankaan ilmanvaihtokoneiden pakkaspudotuksiin. Voitteko välittä tällaista viesti laboratoriohenkilökunnalle. Turvallisuuspäällikkö Pertti Hoskio Oulun yliopisto / Tila- ja turvallisuuspalvelut p. 0294 48 4172, 040-5154901 pertti.hoskio(a)oulu.fi<mailto:pertti.hoskio@oulu.fi> Lähettäjä: Lampainen, Lari <Lari-Pekka.Lampainen(a)fi.issworld.com<mailto:Lari-Pekka.Lampainen@fi.issworld.com>> Lähetetty: 27. tammikuuta 2019 17:33 Vastaanottaja: Pertti Hoskio <Pertti.Hoskio(a)oulu.fi<mailto:Pertti.Hoskio@oulu.fi>> Kopio: 'ext-reijo.karhu(a)sykoy.fi' <ext-reijo.karhu(a)sykoy.fi<mailto:ext-reijo.karhu@sykoy.fi>> Aihe: Tiedote kontinkankaan ilmanvaihtokoneiden pakkaspudotuksiin. Hei, Pertti Tuollainen tiedote liittyen kontinkankaan ilmanvaihtokoneiden pakkaspudotuksiin. Osa koneiden pudotuksista on käyttäjien toimesta huomattu, että vaikuttavat laboratoriotilojen vetokaappien ilmanvaihtoon. Erityisesti Biokemiaan alueella. ________________________________ [iss_logo_62px]Lari Lampainen - Kohdepäällikkö - Tekniset palvelut ISS Palvelut - Elektroniikkatie 2 - 90590 ISS - Oulu, Suomi Puh. +358 400 863 456 - Web: http://www.fi.issworld.com<http://www.fi.issworld.com/> Information in this e-mail and any attachments is confidential and is intended solely for the use of the intended recipient. If you are not the intended recipient, disclosure, dissemination or use of the contents of the e-mail is prohibited. Please delete the e- mail including any attachments and notify the sender that you have received the e-mail by mistake. For other important information concerning this e-mail please click www.issworld.com/disclaimer<http://www.issworld.com/disclaimer> [face]<https://www.facebook.com/duunISSaISSSuomi> [twitter] <https://twitter.com/ISS_Palvelut> [linkedIn] <https://www.linkedin.com/company/iss-palvelut> [cid:image013.png@01D1B59A.C13C4A80] <http://servicefutures.com/> [iaop2016]ISS gets highest global rating six years in a row. In 2018, ISS once again achieved the highest possible rating, five stars, by the International Association of Outsourcing Professionals (IAOP). Read more on important service industry topics on our blog servicefutures.com<http://servicefutures.com>

1 0

FW: Guest lecture by Prof. Valery V. Tuchin
by Katja Riipinen 25 Jan '19

25 Jan '19

From: Teemu Myllylä Sent: perjantai 25. tammikuuta 2019 16.08 To: LTK <ltk-staff(a)oulu.fi> Subject: Guest lecture by Prof. Valery V. Tuchin Dear all, Professor Valery Tuchin will give on Monday 28.1. at 16:00 a presentation about Water migration in the course of optical clearing for normal and pathological tissues. Valery V. Tuchin is a professor and chairman of Optics and Biophotonics at Saratov National Research State University. He is also the head of laboratory, Institute of Precision Mechanics and Control, RAS, and the supervisor of Interdisciplinary laboratory of Biophotonics at National Research Tomsk State University. His research interests include biophotonics, tissue optics, laser medicine, tissue optical clearing, and nanobiophotonics. He is a member of SPIE, OSA, and IEEE, Guest Professor of HUST (Wuhan) and Tianjin Universities of China, and Adjunct Professor of the Limerick University (Ireland) and National University of Ireland (Galway). He is a fellow of SPIE and OSA, and has been awarded Honored Science Worker of the Russia, SPIE Educator Award, OSA/SPIE Joseph W. Goodman Book Writing Award, FiDiPro (Finland), and Chime Bell Prize of Hubei Province (China). Please be welcomed to listen to Prof. Tuchin at lecture hall P117 at 16:00 (in Kontinkangas/Kieppi building). BR, Teemu Teemu Myllylä, Dr.Sc., Adj.Prof. Research Unit of Medical Imaging, Physics and Technology, Faculty of Medicine & Optoelectronics and Measurement Techniques Research Unit, Faculty of Information Technology and Electrical Engineering, University of Oulu, Finland

1 0

Re: [Crc] CRC palaveri 23.1.2019 / CRC meeting 23.1.2019
by Antti Haapalainen 24 Jan '19

24 Jan '19

Hei, Liitteenä asiat, joista keskusteltiin CRC palaverissa 23.1.2019 sekä CRC:n yleinen perehdytys ohje uudelle työntekijälle. Hi, Attached are the things discussed in the CRC meeting 23.1.2019 and a general guide for a new employee. Terv. Antti Haapalainen From: Antti Haapalainen Sent: 21. tammikuuta 2019 14:39 To: 'crc(a)lists.oulu.fi' <crc(a)lists.oulu.fi> Subject: CRC palaveri 23.1.2019 / CRC meeting 23.1.2019 Hei, Pidetään CRC:n palaveri 23.1. klo 8:30 alkaen. Käsiteltävät asiat on mainittu liitteessä. Pidämme palaverin suomeksi. Kirjoitan kokouksesta muistion myös englanniksi, jonka lähetän suomea ei-puhuville. Hi, We will have our next CRC meeting on Wednesday (Jan23) at 8:30 am. The meeting is in Finnish. However, I will prepare a memo of the meeting in English and send it to those who does not speak/understand Finnish. Terveisin, Antti Haapalainen

1 0

FW: 8th Kuopio Stroke Symposium, 5-7 June, Kuopio
by Katja Riipinen 24 Jan '19

24 Jan '19

Subject: FW: 8th Kuopio Stroke Symposium, 5-7 June, Kuopio FYI Subject: 8th Kuopio Stroke Symposium, 5-7 June, Kuopio Dear Colleagues, We cordially invite you to participate in the 8th Kuopio Stroke Symposium, which will take place on 5-7 June 2019 in Kuopio. The series of Kuopio Stroke Symposiums has traditionally focused on prevention, acute care and rehabilitation. With the theme "A global action against stroke" we would like to emphasize the importance of new strategies to overcome stroke burden. To view the program, click uef.fi/stroke<http://www.uef.fi/stroke>. Registration by May 5. The Symposium can be included in the theoretical training of the specialist training. We would appreciate if you could disseminate this information to your colleagues who might be interested to participate in the symposium. The Organizing Committee warmly welcomes you to Kuopio!

1 0

Yliopiston arktinen verkosto/University arctic network
by Emma Pirilä 23 Jan '19

23 Jan '19

[In english below] Hei kaikki, Tuodakseen yhteen yliopistomme arktista tutkimusta ja edistääkseen alan tieteellistä profiilia ja kansainvälistymistä yliopiston rehtoraatti on päättänyt käynnistää arktisen tutkijaverkoston (työnimi: Arctic Research Network) toiminnan. Verkoston valmistelu ja jatkotoimet on osoitettu Thule-instituutille toteutettavaksi yhteistyössä Tellus Innovation Areenan, Tutkimuksen tukipalveluiden, Viestintä- ja markkinointiyksikön sekä Kvantum-instituutin kanssa. Verkosto on samalla osa Arctic Interactions- tutkimuksen profilaatiota. Pyrimme tukemaan yliopiston arktista tutkimusta tekevien tutkijaryhmien kansainvälistä tieteellistä näkyvyyttä ja verkostoitumista. Avaamme ensimmäisen haun helmikuussa. Sitä ennen pyydämme kiinnostuneita ilmoittautumaan tutkijaverkoston tutkijalistalle. Ilmoittautumisesta, tulevasta hausta ja muusta verkostoon liittyvästä lisätietoa infotilaisuudessa. https://www.oulu.fi/thule/node/56848 Tervetuloa infoon 28.1. 2019 klo 10.30-12.00 Tellus Galaxy. Hienoa olisi jos voisitte välittää tapahtumastamme tietoa myös eteenpäin yksikössänne ja verkostoissanne. Lisätietoa verkoston toiminta-ajatuksesta: https://www.oulu.fi/thule/node/56849 yhteistyöterveisin, Arja Rautio Dear researcher, If you are doing research related to Arctic topics, please find information about the new university-level Arctic network. UOulu´s researchers working on Arctic topics as well as the researchers of the Research Institutes situated in UOulu´s different campuses areas are invited to participate in the research activities of the network. The starting point of the network is registration, which will be opened shortly. There will be small grants for international networking for PIs and postdoctoral researchers, who are planning a research project for the calls concerning their expertise in Arctic and northern research. There will be an info-session on 28th of January in Tellus Galaxy at 10.30-12.00 with more information about how to join. More info here: https://www.oulu.fi/thule/node/56848 ************************ Emma Pirilä, PhD Research Funding Specialist Faculty of Medicine Faculty of Biochemistry and Molecular Medicine Biocenter Oulu Aapistie 5A, 2nd floor FIN- 90230 University of Oulu Finland Phone: +358503426428 e-mail: emma.pirila(a)oulu.fi<mailto:emma.pirila@oulu.fi> ************************

1 0

Käytettyjen paristojen hävittäminen / Disposal of used batteries
by Antti Haapalainen 22 Jan '19

22 Jan '19

Hei, Käytetyt paristot toimitetaan ongelmajätteisiin, ja keräysastia löytyy jätehuoneesta 3100B (hissin vierestä). Jokaisen joka käytetyn pariston astiaan vie, pitää peittää navat teipillä (palovaaran takia). Hi, Used batteries have to be disposed in hazardous waste, and the container for this is located in 3100B (next to the elevator). For each used battery, the poles must be covered with tape (due to risk of fire). Terv. Antti Haapalainen

1 0

FW: Precision mammalian model development / rat models - INFRAFRONTIER2020 Project - Trans-national Access call - January 2019
by Reetta Hinttala 22 Jan '19

22 Jan '19

[https://www.infrafrontier.eu]<https://www.infrafrontier.eu> INFRAFRONTIER Research Infrastructure INFRAFRONTIER2020 Project - Trans-national Access call - January 2019 Precision rat model development Call information and application form Context and aim of the call INFRAFRONTIER is the European Research Infrastructure for phenotyping and archiving of model mammalian genomes. The INFRAFRONTIER Research Infrastructure provides access to first-class tools and data for biomedical research, and thereby contributes to improving the understanding of gene function in human health and disease using rodent models. The core services of INFRAFRONTIER comprise the systemic phenotyping of mouse mutants in the participating mouse clinics, and the archiving and distribution of mouse mutant lines by the European Mouse Mutant Archive (EMMA) (www.infrafrontier.eu<https://www.infrafrontier.eu/>). Main objective of this INFRAFRONTIER open call is to facilitate access for the wider biomedical research community to the unique infrastructure and scientific expertise of the participating INFRAFRONTIER partners, to deliver novel rat mutant models that will advance knowledge of human disease and will be of widespread use in biomedical science. Many cognitive and physiological characteristics that make the rat an ideal human disease model and choice for laboratory studies in neurobiology, cardiobiology, and immunology. Recent advances in genome-editing technology will be used to develop new rat models of human disease. INFRAFRONTIER will provide open access to all newly developed disease models through the European Mouse Mutant Archive (EMMA). Access to this free-of-charge-service will be granted on the basis of the applicant’s research plans and the potential impact of the proposed novel rat model on the wider biomedical research community. This Trans-national Access call of the INFRAFRONTIER2020 project supports a total of 3 precision rat model development projects. A complementary call provides support for 12 customised mouse model development projects. More information and call application form: https://www.infrafrontier.eu/resources-and-services/infrafrontier-open-call… Proposal submission to proposals(a)infrafrontier.eu<mailto:proposals@infrafrontier.eu> by 15 February 2019. Proposal evaluation from 15 February 2019 to 15 March 2019. The INFRAFRONTIER2020 project has received funding from the EU Research and Innovation programme Horizon 2020 (H2020-EU.1.4.1.1. Developing new world class research infrastructures) www.infrafrontier.eu<https://www.infrafrontier.eu/> and https://twitter.com/InfrafrontierEU Trans-national Access (TA) activity of the INFRAFRONTIER2020 project Free of charge precision mammalian model development service / Access modalities · The EC Horizon 2020 funded INFRAFRONTIER2020 project (2017 – 2020) supports eligible customers with a free-of-charge rat model development service implemented as a Trans-national Access activity supporting a total of 3 projects in this call. · The access unit offered covers the production of a single F1 genome-edited rat line (at least one individual of a F1 genome edited rat line will be provided). · The model development service using genome editing involves project design, preparation of sgRNAs and Cas9 mRNA/protein, and injection into zygotes to generate F0 founder mutant animals (Sprague Dawley genetic background).Selected F0 animals (very often mosaic) will be bred to germ line to produce F1 genome edited animals. Possible allele types that can be generated are indels, exon deletions (< 10kb) and point mutation insertions. · Newly developed rat models will be made available to selected applicants within an average of 12 months following provision of all required information to start the rat production. · The generated rat models will be made available to the scientific community. An optional grace period of up to 1 year for rat models may apply, with immediate release of rat resources after expiry of the grace period. Rat mutant lines will be deposited into the INFRAFRONTIER/EMMA repository for subsequent use by the scientific community. Newly developed rat models will be owned by the production centres and will be distributed by the INFRAFRONTIER/EMMA repository using their institutional MTAs. · Costs: The access to the INFRAFRONTIER2020 model development service is free of charge. However, the shipment cost of the newly developed rat models must be borne by the applicants. · Eligibility: The INFRAFRONTIER2020 Trans-national Access call is open and proposals can be submitted from applicants around the world. Two projects must be allocated to applicants from EU Member States and Associated Countries, and one project can be allocated to applicants from third countries. · Application: Service requests for the INFRAFRONTIER2020 model development service can be made via an application form<https://www.infrafrontier.eu/resources-and-services/infrafrontier-open-call…>. Applications for the Trans-national Access activity must include a short description of the research plans for utilising the newly developed rat model that is being generated by the INFRAFRONTIER2020 TA service. · Selection procedure: Proposals from eligible customers for free of charge access to the INFRAFRONTIER2020 rat model development service will be subject to a review procedure. The review will be based on short descriptions of the projects involving the rat mutants that will be produced by the TA service. A mixed panel of members of INFRAFRONTIER and of an external Evaluation Committee will assess service requests supported by the TA activity. In addition to scientific merit of applicants, soundness of the proposal and research plans, and the beneficial impact of the proposed novel mouse line on the wider biomedical research community will be assessed. Applicants will be informed on the outcome of the evaluation within 6 weeks after the end of the call for which the TA application was submitted. All applications will be handled with strict confidentiality. · Acknowledgements: Please do acknowledge any support under this scheme in all resulting publications with "Part of this work has been funded by the European Union Research and Innovation programme Horizon 2020 (Grant Agreement Number 730879). The participating infrastructure which provided the service should be specifically mentioned in any publication resulting from the service. INFRAFRONTIER - the European research infrastructure for the generation, phenotyping, archiving and distribution of mammalian models https://www.infrafrontier.eu If you do not wish to receive any further communications or wish to unsubscribe, please follow this link INFRAFRONTIER newsletter form<https://www.infrafrontier.eu/infrafrontier-newsletter/> © INFRAFRONTIER 2019 - all rights reserved

1 0

FW: [EMMA/INFRAFRONTIER directors] Precision mammalian model development / mouse models - INFRAFRONTIER2020 Project -Trans-national Access call - January 2019
by Reetta Hinttala 22 Jan '19

22 Jan '19

[https://www.infrafrontier.eu]<https://www.infrafrontier.eu> INFRAFRONTIER Research Infrastructure INFRAFRONTIER2020 Project - Trans-national Access call - January 2019 Precision mouse model development Call information and application form Context and aim of the call INFRAFRONTIER is the European Research Infrastructure for phenotyping, archiving and distribution of model mammalian genomes. The INFRAFRONTIER Research Infrastructure provides access to first-class tools and data for biomedical research, and thereby contributes to improving the understanding of gene function in human health and disease using the mouse model. The core services of INFRAFRONTIER comprise the systemic phenotyping of mouse mutants in the participating mouse clinics, and the archiving and distribution of mouse mutant lines by the European Mouse Mutant Archive (EMMA) (www.infrafrontier.eu<https://www.infrafrontier.eu>). Main objective of this INFRAFRONTIER open call is to facilitate access for the wider biomedical research community to the unique infrastructure and scientific expertise of the participating INFRAFRONTIER partners, to deliver novel mouse lines that will advance knowledge of human disease and will be of widespread use in biomedical science. Recent advances in genome editing technology will be used to develop new mouse models of human disease. INFRAFRONTIER will provide open access to all newly developed disease models through the European Mouse Mutant Archive (EMMA). Access to this free-of-charge-service will be granted on the basis of the applicant’s research plans and the potential impact of the proposed novel mouse line on the wider biomedical research community. This Trans-national Access call of the INFRAFRONTIER2020 project supports a total of 12 precision mouse model development projects. A complementary call provides support for 3 customised rat model development projects. More information and call application form: https://www.infrafrontier.eu/resources-and-services/infrafrontier-open-call… Proposal submission to proposals(a)infrafrontier.eu<mailto:proposals@infrafrontier.eu> by 15 February 2019. Proposal evaluation from 15 February 2019 to 15 March 2019. The INFRAFRONTIER2020 project has received funding from the EU Research and Innovation programme Horizon 2020 (H2020-EU.1.4.1.1. Developing new world class research infrastructures) www.infrafrontier.eu<https://www.infrafrontier.eu> and https://twitter.com/InfrafrontierEU Trans-national Access (TA) activity of the INFRAFRONTIER2020 project Free of charge precision mammalian model development service / Access modalities · The EC Horizon 2020 funded INFRAFRONTIER2020 project (2017 – 2020) supports eligible customers with a free-of-charge mouse model development service implemented as a Trans-national Access activity supporting a total of 12 projects in this call. · The access unit offered covers the production of a single F1 genome-edited mouse line (at least one individual of a F1 genome edited mouse line will be provided). · The model development service involves project design including prediction of off-target sites, preparation of sgRNA’s and Cas9 mRNA/protein, and injection into zygotes to generate F0 founder mutant animals (C57BL/6N or C57BL/6J genetic background preferred). Selected F0 animals will be bred to germ line to produce F1 genome edited animals. Possible allele types that can be generated are indels, exon deletions (< 10kb) and point mutation insertions. Newly developed mouse models will be made available to selected applicants within an average of 12 months following provision of all required information to start the mouse production. · The generated mouse models will be made available to the scientific community. An optional grace period of up to 1 year for mouse resources may apply, with immediate release of mouse resources after expiry of the grace period. Mouse mutant lines will be deposited into the INFRAFRONTIER/EMMA repository for subsequent use by the scientific community. Newly developed mouse models will be owned by the production centres and will be distributed by the INFRAFRONTIER/EMMA repository using their institutional MTAs. · Costs: The access to the INFRAFRONTIER2020 model development service is free of charge. However, the shipment cost of the newly developed mouse models must be borne by the applicants. · Eligibility: The INFRAFRONTIER2020 Trans-national Access call is open and proposals can be submitted from applicants around the world. Ten projects must be allocated to applicants from EU Member States and Associated Countries, and two projects can be allocated to applicants from third countries. · Application: Service requests for the INFRAFRONTIER2020 model development service can be made via an application form<https://www.infrafrontier.eu/resources-and-services/infrafrontier-open-call…>. Applications for the Trans-national Access activity must include a short description of the research plans for utilising the newly developed mouse model that is being generated by the INFRAFRONTIER2020 TA service. · Selection procedure: Proposals from eligible customers for free of charge access to the INFRAFRONTIER2020 mouse model development service will be subject to a review procedure. The review will be based on short descriptions of the projects involving the mouse mutants that will be produced by the TA service. A mixed panel of members of INFRAFRONTIER and of an external Evaluation Committee will assess service requests supported by the TA activity. In addition to scientific merit of applicants, soundness of the proposal and research plans, and the beneficial impact of the proposed novel mouse line on the wider biomedical research community will be assessed. Applicants will be informed on the outcome of the evaluation within 6 weeks after the end of the call for which the TA application was submitted. All applications will be handled with strict confidentiality. · Acknowledgements: Please do acknowledge any support under this scheme in all resulting publications with "Part of this work has been funded by the European Union Research and Innovation programme Horizon 2020 (Grant Agreement Number 730879). The participating infrastructure which provided the service should be specifically mentioned in any publication resulting from the service. INFRAFRONTIER - the European research infrastructure for the generation, phenotyping, archiving and distribution of mammalian models https://www.infrafrontier.eu If you do not wish to receive any further communications or wish to unsubscribe, please follow this link INFRAFRONTIER newsletter form<https://www.infrafrontier.eu/infrafrontier-newsletter/> © INFRAFRONTIER 2019 - all rights reserved

1 0

AoF FIRI
by Emma Pirilä 21 Jan '19

21 Jan '19

Dear researchers, For those of you who have plans to apply in the Academy of Finland Research Infrastructures (FIRI) call, please find information about the university guidelines and internal deadlines. The AoF requests the universities to make an internal priorisation list and that must be done prior to the AoF deadline. Info in Finnish<https://notio.oulu.fi/fi/Lists/Tiedotteet/DispForm.aspx?ID=710> Info in English<https://notio.oulu.fi/en/Lists/Bulletins/DispForm.aspx?ID=454> Please don't hesitate to contact me should you have questions. Best regards, Emma ************************ Emma Pirilä, PhD Research Funding Specialist Faculty of Medicine Faculty of Biochemistry and Molecular Medicine Biocenter Oulu Aapistie 5A, 2nd floor FIN- 90230 University of Oulu Finland Phone: +358503426428 e-mail: emma.pirila(a)oulu.fi<mailto:emma.pirila@oulu.fi> ************************

1 0

CRC palaveri 23.1.2019 / CRC meeting 23.1.2019
by Antti Haapalainen 21 Jan '19

21 Jan '19

Hei, Pidetään CRC:n palaveri 23.1. klo 8:30 alkaen. Käsiteltävät asiat on mainittu liitteessä. Pidämme palaverin suomeksi. Kirjoitan kokouksesta muistion myös englanniksi, jonka lähetän suomea ei-puhuville. Hi, We will have our next CRC meeting on Wednesday (Jan23) at 8:30 am. The meeting is in Finnish. However, I will prepare a memo of the meeting in English and send it to those who does not speak/understand Finnish. Terveisin, Antti Haapalainen

1 0

Jump to page:

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

Crc